Related Experiment Video
Updated: Aug 24, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Polyamine metabolism in a member of the phylum Microspora (Encephalitozoon cuniculi): effects of polyamine analogues
Cyrus J Bacchi1, Donna Rattendi1, Evangeline Faciane1
1Haskins Laboratories and Department of Biology, Pace University, New York, NY 10038, USA.
Abstract:
The uptake, biosynthesis and catabolism of polyamines in the microsporidian parasite Encephalitozoon cuniculi are detailed with reference to the effects of oligoamine and arylamine analogues of polyamines. Enc. cuniculi, an intracellular parasite of mammalian cells, has both biosynthetic and catabolic enzymes of polyamine metabolism, as demonstrated in cell-free extracts of mature spores. The uptake of polyamines was measured in immature, pre-emergent spores isolated from host cells by Percoll gradient. Spermine was rapidly taken up and metabolized to spermidine and an unknown, possibly acetamidopropanal, by spermidine/spermine N(1)-acetyltransferase (SSAT) and polyamine oxidase (PAO). Most of the spermidine and the unknown product were found in the cell incubation medium, indicating they were released from the cell. bis(Ethyl) oligoamine analogues of polyamines, such as SL-11144 and SL-11158, as well as arylamine analogues [BW-1, a bis(phenylbenzyl) 3-7-3 analogue] blocked uptake and interconversion of spermine at micromolar levels and, in the case of BW-1, acted as substrate for PAO. The Enc. cuniculi PAO activity differed from that found in mammalian cells with respect to pH optimum, substrate specificity and sensitivity to known PAO inhibitors. SL-11158 inhibited SSAT activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine. The interest in Enc. cuniculi polyamine metabolism and the biochemical effects of these polyamine analogues is warranted since they cure model infections of Enc. cuniculi in mice and are potential candidates for human clinical trials.
Insights
Polyamines are crucial for the parasite Encephalitozoon cuniculi, which utilizes both synthesis and breakdown pathways. Novel polyamine analogues effectively inhibit parasite growth and show promise for treating infections.
Area of Science:
- Parasitology
- Biochemistry
- Molecular Biology
Background:
- Polyamines are essential for cell growth and proliferation.
- Microsporidian parasites like Encephalitozoon cuniculi rely on polyamine metabolism for survival.
- Understanding polyamine pathways in E. cuniculi is key to developing new treatments.
Purpose of the Study:
- To investigate the polyamine uptake, biosynthesis, and catabolism in Encephalitozoon cuniculi.
- To evaluate the effects of oligoamine and arylamine analogues on polyamine metabolism in E. cuniculi.
- To characterize the enzymes involved in polyamine metabolism in E. cuniculi and compare them to mammalian counterparts.
Main Methods:
- Analysis of polyamine metabolism in cell-free extracts of mature E. cuniculi spores.
- Measurement of polyamine uptake in immature E. cuniculi spores using Percoll gradient.
- Enzyme assays for spermidine/spermine N(1)-acetyltransferase (SSAT) and polyamine oxidase (PAO) activity.
- Testing the inhibitory effects of polyamine analogues (SL-11144, SL-11158, BW-1) on E. cuniculi polyamine metabolism.
Main Results:
- E. cuniculi possesses both biosynthetic and catabolic enzymes for polyamine metabolism.
- Spermine uptake and metabolism were observed, with products released extracellularly.
- Oligoamine and arylamine analogues inhibited spermine uptake and interconversion at micromolar concentrations.
- BW-1 acted as a substrate for E. cuniculi PAO, which exhibited distinct properties from mammalian PAO.
- SL-11158 showed mixed-type inhibition of SSAT with significantly higher affinity than spermine.
Conclusions:
- E. cuniculi actively metabolizes polyamines, with significant extracellular release of products.
- Polyamine analogues, particularly SL-11158 and BW-1, effectively target E. cuniculi polyamine metabolism.
- The unique biochemical properties of E. cuniculi enzymes offer specific targets for drug development.
- These analogues have demonstrated efficacy in treating E. cuniculi infections in mice and are potential candidates for human clinical trials.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Anthelminthic Agents
Physical Properties of Amines
Antifungal Agents
Diversity of Protists IV
Diversity of Protists II

